1. Home
  2. MMS vs PRCT Comparison

MMS vs PRCT Comparison

Compare MMS & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MMS
  • PRCT
  • Stock Information
  • Founded
  • MMS 1975
  • PRCT 2009
  • Country
  • MMS United States
  • PRCT United States
  • Employees
  • MMS N/A
  • PRCT N/A
  • Industry
  • MMS Business Services
  • PRCT Medical Specialities
  • Sector
  • MMS Consumer Discretionary
  • PRCT Health Care
  • Exchange
  • MMS Nasdaq
  • PRCT Nasdaq
  • Market Cap
  • MMS 4.0B
  • PRCT 3.2B
  • IPO Year
  • MMS 1997
  • PRCT 2021
  • Fundamental
  • Price
  • MMS $71.63
  • PRCT $56.65
  • Analyst Decision
  • MMS Buy
  • PRCT Buy
  • Analyst Count
  • MMS 1
  • PRCT 8
  • Target Price
  • MMS $90.00
  • PRCT $90.00
  • AVG Volume (30 Days)
  • MMS 391.7K
  • PRCT 639.3K
  • Earning Date
  • MMS 08-06-2025
  • PRCT 07-31-2025
  • Dividend Yield
  • MMS 1.65%
  • PRCT N/A
  • EPS Growth
  • MMS 31.21
  • PRCT N/A
  • EPS
  • MMS 5.00
  • PRCT N/A
  • Revenue
  • MMS $5,395,260,000.00
  • PRCT $249,121,000.00
  • Revenue This Year
  • MMS $2.13
  • PRCT $47.40
  • Revenue Next Year
  • MMS $3.36
  • PRCT $31.55
  • P/E Ratio
  • MMS $14.56
  • PRCT N/A
  • Revenue Growth
  • MMS 5.29
  • PRCT 59.36
  • 52 Week Low
  • MMS $63.77
  • PRCT $47.04
  • 52 Week High
  • MMS $93.97
  • PRCT $103.81
  • Technical
  • Relative Strength Index (RSI)
  • MMS 52.49
  • PRCT 43.88
  • Support Level
  • MMS $70.61
  • PRCT $56.67
  • Resistance Level
  • MMS $73.79
  • PRCT $60.06
  • Average True Range (ATR)
  • MMS 1.58
  • PRCT 1.96
  • MACD
  • MMS 0.24
  • PRCT -0.17
  • Stochastic Oscillator
  • MMS 69.68
  • PRCT 15.08

About MMS Maximus Inc.

Maximus Inc designs, develops, and delivers programs, enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments; U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Share on Social Networks: